Market Scope The tenecteplase drug market size is expected to reach USD 2,455.4 million by 2030 at 5.10% CAGR during the forecast period 2022-2030.Tenecteplase drug refers to a recombinant enzyme that acts as a blood thinning agent. Also known as a clot buster, tenecteplase drug helps dissolve blood clots or clumps, allowing the blood to flow normally. These drugs are generally used for...